Literature DB >> 8866602

Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation.

M Drent1, N A Cobben, R F Henderson, E F Wouters, M van Dieijen-Visser.   

Abstract

This review describes the usefulness of monitoring the activity level of lactate dehydrogenase (LDH) and its isoenzyme pattern as indicators of pathological conditions in the lungs, such as cell damage or inflammation. Cytoplasmatic cellular enzymes, like LDH, in the extracellular space, although of no further metabolic function in this space, are still of benefit because they serve as indicators suggestive of disturbances of the cellular integrity induced by pathological conditions. Since LDH is an enzyme present in essentially all major organ systems, serum LDH activity is abnormal in a large number of disorders. Although the increase in total serum LDH activity is rather nonspecific, it is proposed that measurement of LDH activity levels and its isoenzyme pattern in pleural effusion and, more recently, in bronchoalveolar lavage fluid may provide additional information about lung and pulmonary endothelial cell injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866602     DOI: 10.1183/09031936.96.09081736

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  142 in total

1.  A study of salivary lactate dehydrogenase isoenzyme levels in patients with oral leukoplakia and squamous cell carcinoma by gel electrophoresis method.

Authors:  Priya Shirish Joshi; Someshwar Golgire
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

2.  Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models.

Authors:  Mahesh M Ghaisas; Prasad R Dandawate; Suyash A Zawar; Yogesh S Ahire; Santosh P Gandhi
Journal:  Inflammopharmacology       Date:  2010-06-08       Impact factor: 4.473

3.  A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.

Authors:  J S Swaney; C Chapman; L D Correa; K J Stebbins; R A Bundey; P C Prodanovich; P Fagan; C S Baccei; A M Santini; J H Hutchinson; T J Seiders; T A Parr; P Prasit; J F Evans; D S Lorrain
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  The value of BAL fluid LDH level in differentiating benign from malignant solitary pulmonary nodules.

Authors:  Ali Emad; Vahid Emad
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-20       Impact factor: 4.553

5.  NADP+-Preferring D-Lactate Dehydrogenase from Sporolactobacillus inulinus.

Authors:  Lingfeng Zhu; Xiaoling Xu; Limin Wang; Hui Dong; Bo Yu; Yanhe Ma
Journal:  Appl Environ Microbiol       Date:  2015-07-06       Impact factor: 4.792

6.  Poly-ADP-ribose polymerase inhibition provides protection against lung injury in a rat paraquat toxicity model.

Authors:  Salim Kemal Tuncer; Seher Altinel; Mehmet Toygar; Hakan Istanbulluoglu; Kahraman Ates; Recai Ogur; Ozcan Altinel; Yildirim Karslioglu; Turgut Topal; Ahmet Korkmaz; Bulent Uysal
Journal:  Inflammopharmacology       Date:  2016-06-07       Impact factor: 4.473

7.  Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.

Authors:  Lien Van Hoecke; Emma Richelle Job; Xavier Saelens; Kenny Roose
Journal:  J Vis Exp       Date:  2017-05-04       Impact factor: 1.355

8.  Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.

Authors:  Brijeshkumar Patel; Nilesh Gupta; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2014-06-17       Impact factor: 4.200

Review 9.  Clinical use of biomarkers of survival in pulmonary fibrosis.

Authors:  Michiel Thomeer; Jan C Grutters; Wim A Wuyts; Stijn Willems; Maurits G Demedts
Journal:  Respir Res       Date:  2010-06-28

10.  Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses.

Authors:  James A Wiley; Laura E Richert; Steve D Swain; Ann Harmsen; Dale L Barnard; Troy D Randall; Mark Jutila; Trevor Douglas; Chris Broomell; Mark Young; Allen Harmsen
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.